PWP
ALXN

Principle Wealth Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Principle Wealth Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,772
Closed -$326K – 322
2021
Q2 		$326K Hold
1,772
– – 0.04% 242
2021
Q1 		$271K Hold
1,772
– – 0.03% 249
2020
Q4 		$277K Buy
+1,772
New +$228K 0.04% 232
2020
Q3 		– Sell
-1,672
Closed -$188K – 468
2020
Q2 		$188K Buy
+1,672
New +$178K 0.06% 156
2019
Q3 		– Sell
-1,672
Closed -$219K – 171
2019
Q2 		$219K Hold
1,672
– – 0.11% 128
2019
Q1 		$226K Buy
+1,672
New +$208K 0.13% 116

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return